These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35057634)

  • 1. Ferroptosis-related genes are candidate diagnostic and prognostic biomarkers for skin cutaneous melanoma.
    Jing HY; Gu W; Tan XY; Ma YR
    Biomark Med; 2022 Feb; 16(3):179-196. PubMed ID: 35057634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi
    Wu M; Li K; Liao Y; Li L; Xiao X; Chen Y; Guo J; Hu F; Qu J; Wang Z; Feng H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 49(2):159-174. PubMed ID: 38755712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and validation of a ferroptosis-related gene signature for predicting survival in skin cutaneous melanoma.
    Ping S; Wang S; Zhao Y; He J; Li G; Li D; Wei Z; Chen J
    Cancer Med; 2022 Sep; 11(18):3529-3541. PubMed ID: 35373463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma Molecular Subtypes and Development of Prognostic and Immunotherapy-Related Genetic Characteristics by Ferroptosis Gene Analysis.
    Xu L; Zhang Y; Liu T; Wang L; Zhao Z; Zhang X; Li X; Wu W; Yu S
    Comput Math Methods Med; 2022; 2022():2992939. PubMed ID: 35516454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring a 7-gene prognostic model based on ferroptosis for efficiently guiding immunotherapy in melanoma patients.
    Zhang X; Ding C; Zhao Z
    Adv Med Sci; 2022 Sep; 67(2):364-378. PubMed ID: 36155341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of ferroptosis-related genes and prognosis of cutaneous melanoma.
    Liu C; Liu Y; Yu Y; Zhao Y; Yu A
    BMC Med Genomics; 2022 Mar; 15(1):39. PubMed ID: 35232428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a biomarker signature associated with anoikis to predict prognosis and immunotherapy response in melanoma.
    Wu Z; Zhang R; Bao J; Yin M; Wang X
    Arch Dermatol Res; 2024 May; 316(6):219. PubMed ID: 38787413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RARRES1 identified by comprehensive bioinformatic analysis and experimental validation as a promising biomarker in Skin Cutaneous Melanoma.
    Liu M; Bai R; Zhang G; Liu X; Wang Z; He K; Gan X; Zhou X; Yin P; Zheng Y; Wang G
    Sci Rep; 2024 Jun; 14(1):14113. PubMed ID: 38898266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of ferroptosis-related lncRNA signature as a prognostic model for skin cutaneous melanoma.
    Guo S; Chen J; Yi X; Lu Z; Guo W
    Front Immunol; 2022; 13():985051. PubMed ID: 36248853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nucleosome remodeling and deacetylase complex has prognostic significance and associates with immune microenvironment in skin cutaneous melanoma.
    Liu X; Wang J
    Int Immunopharmacol; 2020 Nov; 88():106887. PubMed ID: 32799111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Ferroptosis-Related lncRNA Prognostic Model and Immune Infiltration Features in Skin Cutaneous Melanoma.
    Sun S; Zhang G; Zhang L
    Front Cell Dev Biol; 2021; 9():790047. PubMed ID: 35186949
    [No Abstract]   [Full Text] [Related]  

  • 12. A new ferroptosis-related genetic mutation risk model predicts the prognosis of skin cutaneous melanoma.
    He J; Huang W; Li X; Wang J; Nie Y; Li G; Wang X; Cao H; Chen X; Wang X
    Front Genet; 2022; 13():988909. PubMed ID: 36685905
    [No Abstract]   [Full Text] [Related]  

  • 13. Comprehensive analysis of the prognosis and biological significance for IFIT family in skin cutaneous melanoma.
    Jiang Y; Zhang C; Zhang J; Han D; Shi X
    Int Immunopharmacol; 2021 Dec; 101(Pt A):108344. PubMed ID: 34763233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of differential gene immune infiltration and clinical characteristics of skin cutaneous melanoma based on systems biology and drug repositioning methods to identify drug candidates for skin cutaneous melanoma.
    Long S; Xu J; Huang H
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2427-2447. PubMed ID: 37086280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PMEL as a Prognostic Biomarker and Negatively Associated With Immune Infiltration in Skin Cutaneous Melanoma (SKCM).
    Zhang S; Chen K; Liu H; Jing C; Zhang X; Qu C; Yu S
    J Immunother; 2021 Jul-Aug 01; 44(6):214-223. PubMed ID: 34028390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Overexpression of SLC25A13 Predicts Poor Prognosis and Is Correlated with Immune Cell Infiltration in Patients with Skin Cutaneous Melanoma.
    Lv Y; Yuan CH; Han LY; Huang GR; Ju LC; Chen LH; Han HY; Zhang C; Zeng LH
    Dis Markers; 2022; 2022():4091978. PubMed ID: 35607442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. System analysis based on the pyroptosis-related genes identifes GSDMD as a novel therapy target for skin cutaneous melanoma.
    Zhao S; Zhu Y; Liu H; He X; Xie J
    J Transl Med; 2023 Nov; 21(1):801. PubMed ID: 37950289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
    Tian Q; Gao H; Zhao W; Zhou Y; Yang J
    Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel tumour microenvironment-based prognostic biomarker in skin cutaneous melanoma.
    Yang RH; Liang B; Li JH; Pi XB; Yu K; Xiang SJ; Gu N; Chen XD; Zhou ST
    J Cell Mol Med; 2021 Dec; 25(23):10990-11001. PubMed ID: 34755462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic expression analysis of EAF family reveals the importance of EAF2 in melanoma.
    Han W; Shen GL
    Int Immunopharmacol; 2020 Nov; 88():106958. PubMed ID: 33182068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.